Nevertheless, compared with shSTK4 treatment alone, the presence of shlncRNA TNRC6C‐AS1 or RA‐V(1) with shSTK4 significantly slowed down tumour growth (P < .05) (Figure 6A‐C). This evidence concerns the gene TNRC6C and neoplasm.